Celltex Therapeutics Corporation Logo
  • ESPAÑOL
  • Enroll Today
  • Request Information
  • Contact Us
  • Therapy Services
  • Stem Cell Banking
  • The Celltex Difference
  • How It Works
  • Our Science & Lab
  • View Clinical Trials
  • Conditions, Disorders & Diseases
  • Frequently Asked Questions
  • News & Press
  • Client Results
  • Client Stories
  • Client Assessment
  • Attend a Webinar
  • View our Online Webinar
  • View More

Connect

  • Facebook
  • Twitter
  • Instagram
  • LinkedIn
  • Vimeo

Partners

  • Medical Professionals

Legal

  • Privacy Policy
  • Terms & Conditions

© 2026 Celltex Therapeutics Corporation. All rights reserved.

Celltex Therapeutics Corporation Logo Celltex Logo
  • ESPAÑOL
  • Enroll Today
  • Request Information
  • Contact Us
  • Products & Services
    • Therapy
    • Stem Cell Banking
    • The Celltex Difference
  • How It Works
    • How It Works
    • Our Science & Lab
    • Conditions, Disorders & Diseases
  • Results
    • Clinical Trials
    • Client Results
    • Client Stories
  • Resources
    • Stem Cell 101
    • Attend a Webinar
    • View Previous Webinars
    • Request Information
    • Client Assessment
    • Extraction Sites
    • For Physicians
    • Company Information
    • Careers
  • FAQs
  • News

Celltex News

News & Press

Company Update

Maxine Snapka Becomes First Celltex Client to Celebrate 100 Years

January 20, 2023

Long-time Celltex client Maxine Snapka celebrated her 100th birthday, becoming the first centenarian working with Celltex to keep living life well regardless of age. Inspired by her dedication to health and wellness, Celltex celebrated her achievement by awarding her the first-ever Celltex Centenarian Award.

Learn More
Company Update

Andrews Medicine and Celltex Therapeutics Corporation Join Forces to Bring Cutting Edge Technologies to Athletic Injuries

October 4, 2022

James R. “Jim” Andrews, MD, Chairman and CEO of Andrews Medicine of Pensacola, Florida, and David G. Eller, Chairman and CEO of Celltex Therapeutics Corporation of Houston, Texas, announced today that together they will form a new biotechnology company to bridge the divide between stem cell research and the current treatment of athletic injuries.

Learn More
In the News

Fox 26: Bedridden child matures into a healthy mother of two thanks to stem cells

March 3, 2021

Sarah spent most of her life in a hospital bed until Celltex used her own stem cells to heal her body. She’s doing better than anyone ever imagined, and now she’s helping others who are desperate for medical help.

Learn More
In the News

Stem Cell Journals: Development of COVID‐19 Therapies from Birthing Tissues and Cord Blood

October 28, 2020

Celltex Therapeutics Corporation was mentioned in the Stem Cell Journals publication as one of the five largest stem cell therapy trials using MSCs to fight COVID in an article titled “Development of COVID‐19 Therapies from Birthing Tissues and Cord Blood”.

Learn More
In the News

Fox 26 Houston: Houston company gets green light to study your own stem cells to prevent COVID-19

August 7, 2020

Promising news out of Houston from a company that got the FDA’s clearance to try to use a person’s own stem cells to prevent COVID-19. Celltex Therapeutics Corporation is also hoping the stem cells will help treat some of the more severe cases.

Learn More
In the News

Business Wire: Former U.S. Secretary of Energy and Texas Governor, Rick Perry, Names Two Texas Companies as Leading Innovators in the Fight Against COVID-19

August 3, 2020

Celltex Therapeutics obtains approval from FDA to evaluate Celltex’s Mesenchymal Stem Cells as prevention against COVID-19 and Medistar Corporation’s biodefense HVAC filter to destroy nearly 100% of the virus

Learn More
In the News

KSAT: Could the key to defeating COVID-19 lie within our own cells?

July 22, 2020

The key to defeating and preventing COVID-19 may lie within our own cells, according to a San Antonio doctor who aims to prove that theory with several studies just recently approved by the U.S. Food and Drug Administration.

Learn More
Company Update

Celltex on Talking with Tony Buzbee KSEV Radio Show

July 22, 2020

Learn More
Company Update

Celltex Therapeutics Receives Another FDA Approval: Phase II Clinical Trial Using Mesenchymal Stem Cells (MSCs) as a Prophylactic Against COVID-19

July 1, 2020

Learn More
Company Update

Rick Perry Discusses Celltex’s COVID-19 Clinical Trials on Fox News TV

June 30, 2020

Former U.S. Secretary of Energy and former Governor of Texas, Rick Perry, was on Fox News TV discussing Celltex’s COVID-19 ongoing clinical trials and the ingenuity that will deliver a victory over this virus.

Learn More

Posts navigation

Older posts
Newer posts

Post Types

  • Press Releases & Company Updates
  • Celltex in the News
  • Blog Posts & Client Stories

Topics

adult stem cell therapy alzheimer Andrews Celltex Biologics Andrews Medicine arthritis autoimmune condition Biologic License biotech companies brain injury business development celltex team chronic illness clinical research clinical trial david eller FDA fight for stem cell therapy innovation in the news Investigational New Drug medical research miracle story MS MS research multiple sclerosis news reference Orthopedics pain relief Parkinson's disease partnership president trump press release Regenerative Medicine Research saudi arabia Sports Injury Program Sports Medicine stem cell banking stem cell law stem cell laws stem cell therapy stem cell therapy for alzheimers stem cell therapy in texas stem cell treatment success stories

Media Contacts

For media inquiries, please contact Lisa Spence at 713-552-1055.

Celltex Logo
  • ESPAÑOL
  • Enroll Today
  • Request Information
  • Contact Us

Connect

  • Facebook
  • Twitter
  • Instagram
  • LinkedIn
  • Vimeo

About

  • Company Information
  • About Celltex
  • Board of Directors
  • Executive Team
  • Client Services Team
  • Celltex Mexico
  • Site Map
  • News & Press
  • Careers

Partners

  • Medical Professionals

Legal

  • Privacy Policy
  • Terms & Conditions

© 2026 Celltex Therapeutics Corporation. All rights reserved.